Glenys R. Chidlow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Glenys R. Chidlow has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
David W. Smith
Department of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Australia
2 shared publications- David W. Smith
PathWest Laboratory Medicine Western Australia, Nedlands, WA 6009, Australia
2 shared publications Gerald B. Harnett
Department of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Australia
2 shared publications- Simon Hedley Williams
Center for Infection and Immunity, Columbia University, New York, New York, USA
2 shared publications - Aeron Christopher Hurt
WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; University of Melbourne, Department of Microbiology and Immunology, Parkville, VIC 3010, Australia
1 shared publication - Andrew R. Greenhill
Federation University, Microbiology Research Group, Institute of Innovation, Science and Sustainability
1 shared publication
Latest Publications
- Open Access
- 16 May 2012
- Published by Elsevier in Journal of Clinical Virology
- Vol. 54 (3) , 235-239
Respiratory viral pathogens associated with lower respiratory tract disease among young children in the highlands of Papua New Guinea
- 16 May 2012
- Published by Elsevier in Journal of Clinical Virology
- Vol. 54 (3) , 235-239
Open AccessRespiratory viral pathogens associated with lower respiratory tract disease among young children in the highlands of Papua New Guinea
- 1 September 2011
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 49 (9) , 3444-3445
Evaluation of Real-Time Reverse Transcriptase PCR Assays for Detection of Pandemic Influenza A/H1N1 2009 Virus
- 1 September 2011
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 49 (9) , 3444-3445
Evaluation of Real-Time Reverse Transcriptase PCR Assays for Detection of Pandemic Influenza A/H1N1 2009 Virus
- 1 October 2010
- Published by Elsevier in Journal of Virological Methods
- Vol. 169 (1) , 47-51
The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay
- 1 October 2010
- Published by Elsevier in Journal of Virological Methods
- Vol. 169 (1) , 47-51
The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay
- 1 March 2010
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (3) , 862-866
Duplex Real-Time Reverse Transcriptase PCR Assays for Rapid Detection and Identification of Pandemic (H1N1) 2009 and Seasonal Influenza A/H1, A/H3, and B Viruses
Reports of a novel influenza virus type A (H1N1), now designated by the World Health Organization as pandemic (H1N1) 2009, emerged from the United States and Mexico in April 2009. The management of the pandemic in Australia required rapid and reliable testing of large numbers of specimens for the novel influenza strain and differentiation from seasonal influenza strains. A real-time reverse transcriptase PCR (RT-PCR) assay for the detection of pandemic (H1N1) 2009 was designed and used with existing real-time RT-PCR assays for seasonal influenza viruses A and B. MS2 coliphage was added to all samples and amplified as a quality control. Three duplex RT-PCR assays, each containing two primer pairs and corresponding 5′ nuclease probes, were initially evaluated on control material and stored samples and showed high sensitivity and specificity. More than 11,000 clinical samples were then tested for influenza A and B matrix gene targets and specific hemagglutinin gene targets for seasonal influenza A/H1, A/H3, and pandemic A (H1N1) 2009. Minimum sensitivities and specificities were 98.8% and 100%, respectively, for pandemic (H1N1) 2009, 81.5% and 98.9% for seasonal A/H1, and 96.3% and 99.6% for A/H3. Automated sample extraction facilitated the rapid processing of samples so that the assays allowed accurate, rapid, and cost-effective screening of large numbers of clinical samples.
- 1 March 2010
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (3) , 862-866
Duplex Real-Time Reverse Transcriptase PCR Assays for Rapid Detection and Identification of Pandemic (H1N1) 2009 and Seasonal Influenza A/H1, A/H3, and B Viruses
Reports of a novel influenza virus type A (H1N1), now designated by the World Health Organization as pandemic (H1N1) 2009, emerged from the United States and Mexico in April 2009. The management of the pandemic in Australia required rapid and reliable testing of large numbers of specimens for the novel influenza strain and differentiation from seasonal influenza strains. A real-time reverse transcriptase PCR (RT-PCR) assay for the detection of pandemic (H1N1) 2009 was designed and used with existing real-time RT-PCR assays for seasonal influenza viruses A and B. MS2 coliphage was added to all samples and amplified as a quality control. Three duplex RT-PCR assays, each containing two primer pairs and corresponding 5′ nuclease probes, were initially evaluated on control material and stored samples and showed high sensitivity and specificity. More than 11,000 clinical samples were then tested for influenza A and B matrix gene targets and specific hemagglutinin gene targets for seasonal influenza A/H1, A/H3, and pandemic A (H1N1) 2009. Minimum sensitivities and specificities were 98.8% and 100%, respectively, for pandemic (H1N1) 2009, 81.5% and 98.9% for seasonal A/H1, and 96.3% and 99.6% for A/H3. Automated sample extraction facilitated the rapid processing of samples so that the assays allowed accurate, rapid, and cost-effective screening of large numbers of clinical samples.
- Open Access
An Economical Tandem Multiplex Real-Time PCR Technique for the Detection of a Comprehensive Range of Respiratory Pathogens
This study used real-time PCR assays to screen small sample volumes for a comprehensive range of 35 respiratory pathogens. Initial thermocycling was limited to 20 cycles to avoid competition for reagents, followed by a secondary real-time multiplex PCR. Supplementary semi-nested human metapneumovirus and picornavirus PCR assays were required to complete the acute respiratory pathogen profile. Potential pathogens were detected in 85 (70%) of pernasal aspirates collected from 121 children with acute respiratory symptoms. Multiple pathogens were detected in 29 (24%) of those samples. The tandem multiplex real-time PCR was an efficient method for the rapid detection of multiple pathogens.
Open AccessAn Economical Tandem Multiplex Real-Time PCR Technique for the Detection of a Comprehensive Range of Respiratory Pathogens
This study used real-time PCR assays to screen small sample volumes for a comprehensive range of 35 respiratory pathogens. Initial thermocycling was limited to 20 cycles to avoid competition for reagents, followed by a secondary real-time multiplex PCR. Supplementary semi-nested human metapneumovirus and picornavirus PCR assays were required to complete the acute respiratory pathogen profile. Potential pathogens were detected in 85 (70%) of pernasal aspirates collected from 121 children with acute respiratory symptoms. Multiple pathogens were detected in 29 (24%) of those samples. The tandem multiplex real-time PCR was an efficient method for the rapid detection of multiple pathogens.